US Archives - Page 131 of 173 - European Medical Journal

Polygenic Risk Scores May Enhance Active Surveillance for Prostate Cancer

A recent study suggests multi-ancestry polygenic risk scores (PRS) may help refine active surveillance strategies for low- to intermediate-risk prostate cancer.

Examining Physiologic Volar Macules in Diverse Populations

This study highlights the importance of recognizing physiologic volar melanotic macules in clinical practice, particularly in individuals with skin of color

Chronic Conditions Worsen Outcomes for COPD Patients

A study reveals that COPD patients with comorbidities such as GERD, diabetes, and osteoporosis face higher risks of exacerbations and increased healthcare visits, underscoring the need for integrated care strategies to improve outcomes.

Real-World Raynaud’s Management in Systemic Sclerosis

Raynaud’s phenomenon (RP) in systemic sclerosis (SSc) can lead to chronic digital ischemia, ulcerations, and necrosis with significant…

AMJ Rheumatology 1.1 2024

What’s redefining rheumatology in 2024? In this issue of AMJ Rheumatology, we unpack the pivotal moments of American College of…

Review of the American College of Rheumatology (ACR) Convergence 2024

SET against the vibrant backdrop of Washington, D.C., this year’s American College of Rheumatology (ACR) Convergence was truly…

Current Applications and Future Roles of AI in Rheumatology

AI is the process of simulation of human intelligence by computer systems. These processes encompass learning, reasoning, and…

Rheumatology’s Most Impactful Discoveries This Year

EXPERTS at the American College of Rheumatology (ACR) Convergence 2024 identified and showcased the most groundbreaking discoveries in the…

AI Tool Predicts Early Flare in Rheumatic Diseases

Rheumatic and musculoskeletal diseases (RMD) affect up to one-third of the UK population, are the number one cause of disability, and are…

Harnessing the Power of AI in Rheumatology

THIS year’s American College of Rheumatology (ACR) Convergence, which took place from Novemeber 14th–19th 2024 in Washington, D.C., saw…